| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1
* Department of Clinical Pharmacology, Research Institute, International Medical Center of Japan, Tokyo, Japan;
PRESTO, Japan Science and Technology Agency, Saitama, Japan;
Department of Bacteriology, Nara Medical University, Kashihara, Japan;
Department of Medical Ecology and Informatics, Research Institute, International Medical Center of Japan, Tokyo, Japan; and
|| Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
1Correspondence: Department of Clinical Pharmacology, Research Institute, International Medical Center of Japan, 1–21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. E-mail: knishika{at}ri.imcj.go.jp
ABSTRACT
Infection with Shiga toxin (Stx)-producing Escherichia coli O157:H7 causes bloody diarrhea and hemorrhagic colitis in humans, sometimes resulting in fatal systemic complications. Among the known Stx family members, Stx2 is responsible for the most severe forms of disease. Stx2 binds to target cells via multivalent interactions between its B-subunit pentamer and globotriaosyl ceramide. After binding, it is first retrogradely transported to the Golgi and then to the endoplasmic reticulum (ER). Using a multivalent peptide library approach, we identified a tetravalent peptide that exhibits a high affinity for the Stx2 B-subunit pentamer (KD=0.13 µM) and markedly inhibits Stx2 cytotoxicity. The tetravalent peptide exerted its inhibitory effects by inducing aberrant cellular transport of Stx2. Although the tetravalent peptide/Stx2 complex was incorporated into cells and translocated to the Golgi, this process was followed by the effective degradation of Stx2 in an acidic compartment rather than by its transfer to the ER. This peptide thoroughly protected mice from a fatal dose of E. coli O157:H7 even when administered after an established infection. Thus, the multivalent peptide library approach enabled the identification of a peptide-based Stx2 inhibitor that has remarkable therapeutic potency and appears to function by inducing aberrant cellular transport and degradation of Stx2.—Nishikawa, K., Watanabe, M., Kita, E., Igai, K., Omata, K., Yaffe, M. B., Natori, Y. A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin.
This article has been cited by other articles:
|
|
 |
|
  L. Winkler, C. Gehring, A. Wenzel, S. L. Muller, C. Piehl, G. Krause, I. E. Blasig, and J. Piontek Molecular Determinants of the Interaction between Clostridium perfringens Enterotoxin Fragments and Claudin-3 J. Biol. Chem., July 10, 2009; 284(28): 18863 - 18872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kano, S. Yamauchi, Y. Yoshida, M. Watanabe-Takahashi, K. Nishikawa, N. Nakamura, and M. Murata Yip1A regulates the COPI-independent retrograde transport from the Golgi complex to the ER J. Cell Sci., July 1, 2009; 122(13): 2218 - 2227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vareille, T. de Sablet, T. Hindre, C. Martin, and A. P. Gobert Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli PNAS, June 12, 2007; 104(24): 10199 - 10204. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
